ROIVANT SCIENCES LTD. (ROIV) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$365.39M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA $415.88M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$338.46M*; Operating income -$339.15M; Depreciation and amortization $691.00K*.
- 2025-09-30: Basis Reported; EBITDA -$305.31M*; Operating income -$306.23M; Depreciation and amortization $921.00K*.
Complete source-backed ebitda history.
- Available history
- 2022-03-31 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$365.39M | (m) | (m) | (m) | -25339.32% | $419.00K | -$270.50M | (m) | $202.02M | (m) | -$3.96M |
|---|
| 2026-03-31 | Reported | $415.88M | (m) | (m) | (m) | 16503.10% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$338.46M* | -$339.15M | $691.00K* | $2.00M | -16931.57%* | -$4.93M* | -$196.48M* | (m) | $165.38M | (m) | $23.33M |
|---|
| 2025-09-30 | Reported | -$305.31M* | -$306.23M | $921.00K* | $1.57M | -19434.25%* | $7.85M* | -$185.66M* | (m) | $164.57M | (m) | $7.00M |
|---|
| 2025-06-30 | Reported | -$283.82M | (m) | (m) | (m) | -13079.45% | $4.04M | -$204.38M | (m) | $152.92M | (m) | $4.65M |
|---|
| 2025-03-31 | Reported | -$283.54M | (m) | (m) | (m) | -3745.57% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$271.46M* | -$274.38M | $2.92M* | $9.02M | -3010.20%* | $1.83M* | -$207.25M* | (m) | $141.59M | (m) | -$25.57M |
|---|
| 2024-09-30 | Reported | -$336.87M* | -$341.71M | $4.84M* | $4.47M | -7527.84%* | $996.00K* | -$266.81M* | (m) | $143.07M | (m) | $12.46M |
|---|
| 2024-06-30 | Reported | -$97.35M | (m) | (m) | (m) | -1218.42% | $965.00K | -$192.83M | (m) | $120.51M | $148.52M | $11.96M |
|---|
| 2024-03-31 | Reported | -$201.61M | (m) | (m) | (m) | -2235.13% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-12-31 | Reported | $5.13B* | $5.13B | $5.38M* | $15.56M | 32983.16%* | $355.00K* | -$210.45M* | (m) | $108.15M | $197.28M | $22.36M |
|---|
| 2023-09-30 | Reported | -$208.30M* | -$213.89M | $5.59M* | $3.65M | -5710.09%* | $275.00K* | -$196.43M* | (m) | $114.79M | $164.35M | $3.24M |
|---|
| 2023-06-30 | Reported | -$270.57M | (m) | (m) | (m) | -1251.27% | $403.00K | -$249.93M | (m) | $125.13M | $156.19M | $1.75M |
|---|
| 2023-03-31 | Reported | $40.34M | (m) | (m) | (m) | -1699.33% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$372.93M* | -$378.08M | $5.15M* | $17.05M | -2186.99%* | $508.00K* | -$222.59M* | (m) | $125.53M | $168.26M | $2.82M |
|---|
| 2022-09-30 | Reported | -$275.69M* | -$280.77M | $5.08M* | $12.53M | -2199.72%* | $3.10M* | -$189.63M* | (m) | $132.00M | $157.66M | $2.17M |
|---|
| 2022-06-30 | Reported | -$279.63M | (m) | (m) | (m) | -6474.44% | $7.46M | -$252.08M | (m) | $135.83M | $149.07M | $4.00M |
|---|
| 2022-03-31 | Reported | -$265.1M | (m) | (m) | (m) | -2874.30% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$244.65M* | -$246.02M | $1.37M* | $24.34M | -1005.11%* | $6.07M* | -$268.49M* | (m) | $137.34M | $115.53M | $38.00K |
|---|
| 2021-09-30 | Reported | (m) | -$684.43M | (m) | $13.99M | (m) | $2.76M* | -$120.60M* | (m) | $132.10M | $437.78M | $401.00K |
|---|
| 2021-06-30 | Reported | (m) | -$154.39M | (m) | $7.74M | (m) | $2.34M | -$141.17M | (m) | $78.52M | (m) | $93.00K |
|---|
| 2020-12-31 | Reported | (m) | -$259.07M | (m) | $5.75M | (m) | $107.00K* | -$236.86M* | (m) | $202.26M | (m) | -$224.00K |
|---|
| 2020-09-30 | Reported | (m) | -$156.54M | (m) | $1.32M | (m) | $1.30M* | -$98.05M* | (m) | $97.41M | (m) | $711.00K |
|---|
| 2020-06-30 | Reported | (m) | -$114.45M | (m) | $1.58M | (m) | $306.00K | -$111.17M | (m) | $58.73M | (m) | $1.22M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-03-31 | Reported | -$511.72M | (m) | (m) | (m) | -6195.16% | $8.21M | -$750.35M | (m) | $681.81M | (m) | $133.33M |
|---|
| 2025-03-31 | Reported | -$989.22M | (m) | (m) | (m) | -3404.89% | $4.60M | -$839.45M | (m) | $550.41M | (m) | $48.17M |
|---|
| 2024-03-31 | Reported | $4.52B | (m) | (m) | (m) | 13814.29% | $1.38M | -$765.27M | (m) | $439.91M | $687.44M | $21.50M |
|---|
| 2023-03-31 | Reported | -$887.91M | (m) | (m) | (m) | -2816.07% | $12.69M | -$843.39M | (m) | $454.06M | $600.51M | $4.08M |
|---|
| 2022-03-31 | Reported | -$1.35B | (m) | (m) | (m) | -2434.09% | $17.44M | -$677.73M | (m) | $483.04M | $775.03M | $369.00K |
|---|
| 2021-03-31 | Reported | (m) | -$1.07B | (m) | $23.80M | (m) | $5.81M | -$552.14M | (m) | $236.63M | (m) | $1.69M |
|---|